SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 368 filers reported holding SAREPTA THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is 1.02 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $44,668,600 | +1254.3% | 368,492 | +1179.5% | 1.06% | +1375.0% |
Q2 2023 | $3,298,176 | -86.1% | 28,800 | -83.2% | 0.07% | -85.2% |
Q1 2023 | $23,660,311 | +3854.8% | 171,663 | +3618.1% | 0.48% | +3364.3% |
Q4 2022 | $598,271 | -62.8% | 4,617 | -68.3% | 0.01% | -65.0% |
Q3 2022 | $1,609,000 | +35.1% | 14,561 | -8.4% | 0.04% | +29.0% |
Q2 2022 | $1,191,000 | -69.2% | 15,890 | -63.0% | 0.03% | -65.9% |
Q4 2021 | $3,872,000 | +16.3% | 43,000 | +19.4% | 0.09% | -1.1% |
Q3 2021 | $3,329,000 | +665.3% | 36,000 | +542.9% | 0.09% | +557.1% |
Q2 2021 | $435,000 | +86.7% | 5,600 | +186.0% | 0.01% | -39.1% |
Q1 2019 | $233,000 | -77.7% | 1,958 | -93.7% | 0.02% | -89.4% |
Q2 2017 | $1,045,000 | -3.5% | 31,000 | -15.3% | 0.22% | +7.4% |
Q1 2017 | $1,083,000 | +286.8% | 36,600 | +258.8% | 0.20% | +215.6% |
Q4 2016 | $280,000 | -41.8% | 10,200 | +30.3% | 0.06% | -38.5% |
Q3 2016 | $481,000 | -49.0% | 7,830 | -83.8% | 0.10% | -71.2% |
Q1 2016 | $943,000 | – | 48,300 | – | 0.36% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Perceptive Advisors | 2,878,979 | $69,182,000 | 7.27% |
Eventide Asset Management | 259,100 | $6,226,000 | 0.97% |
GLADE BROOK CAPITAL PARTNERS LLC | 251,000 | $6,032,000 | 0.93% |
IMS Capital Management | 32,215 | $774,000 | 0.91% |
Perceptive Advisors | 350,000 | $8,413,000 | 0.88% |
Benchmark Capital Advisors | 34,900 | $839,000 | 0.58% |
BECK CAPITAL MANAGEMENT, LLC | 24,744 | $636,000 | 0.49% |
SABBY MANAGEMENT, LLC | 352,100 | $8,461,000 | 0.47% |
Hatteras Alternative Mutual Funds, LLC | 39,404 | $947,000 | 0.46% |
Potomac Capital Management, Inc. | 22,100 | $531,000 | 0.45% |